FDA Adverse Event Malfunction Summary report: N

SUPPRELIN LA IMPLANT

MDR report key: 2193250 · Received July 26, 2011

Report

Report Number
2193250
Event Type
Malfunction
Date Received
July 26, 2011
Date of Event
July 20, 2011
Report Date
July 25, 2011
Manufacturer
ENDO PHARMACEUTICAL
Product Code
MDM
Product Problem
Yes
Report Source
User Facility report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Description of Event or Problem · 1

SUPPRELIN LA IMPLANT PLACED (B)(6) 2010. DURING EXPLANTATION ON (B)(6) 2011 IMPLANT FOUND BROKEN IN THREE PIECES. SURGEON INITIALLY ABLE TO RETRIEVE ONE PORTION OF IMPLANT AND UNABLE TO PALPATE REMAINING DEVICE. PLAIN FILM RADIOLOGY DONE BUT UNABLE TO SEE DEVICE - NOT RADIOPAQUE. SONOGRAPHY USED WITH ASSISTANCE OF ANOTHER PHYSICIAN AND REMAINING 2 FRAGMENTS REMOVED. PER SURGEON, THIS WAS A VARIATION TO HIS PRIOR EXPERIENCE WITH THIS DEVICE. THIS WAS ONE OF FOUR IMPLANTS THAT BROKE DURING EXPLANTATION IN A 2 DAY PERIOD. SURGEON VERBALIZED THE INTEGRITY OF IMPLANTS PLACED APPROXIMATELY ONE YEAR AGO ARE INFERIOR TO IMPLANTS IN PRIOR 18 MONTHS AND BEYOND.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SUPPRELIN LA IMPLANT BODY/CAPSULE OF HORMONE IMPLANT MDM ENDO PHARMACEUTICAL 67979-002-01 9K2331

Patients

Seq Age Sex Outcome Treatment
1 11 YR Other